• Making Sense of Sex in Clinical Trials

    Clinical Research News | Roughly two-thirds of pivotal clinical trials leading to a drug approval by the U.S. Food and Drug Administration (FDA) now include women at rates either at or above the disease burden on the female population. Yet progress on their inclusion has “plateaued” since the FDA began releasing its Drug Trials Snapshots in 2015 because of “fundamental issues in not considering female biology."

    Nov 12, 2025

  • Less Can Be More When It Comes to Collecting Data in Studies

    Clinical Research News | It is no secret that clinical trial protocols have grown increasingly complex, resulting in longer study durations, higher costs, and greater burden on patients and investigative sites. It has been a consistent, well-documented trend for more than two decades now.

    Nov 11, 2025

  • Next-Gen Weight-Loss Drug Moves Closer to Clinical Trials

    Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound.

    Nov 6, 2025

  • Site Payments: Transparency, Timeliness, and Trust

    Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound.

    Nov 5, 2025

  • AI in Clinical Trials: Industry Leaders Discuss Implementation Challenges and Future Directions

    Clinical Research News | At SCOPE Europe, I hosted a panel of pharmaceutical industry leaders to discuss the real-world implementation of artificial intelligence in clinical trials, moving beyond theoretical benefits to address practical challenges and measurable outcomes.

    Nov 4, 2025

  • AI in Clinical Trials: Industry Leaders Discuss Implementation Challenges and Future Directions

    Clinical Research News | At SCOPE Europe, Allison Proffitt hosted a panel of pharmaceutical industry leaders to discuss the real-world implementation of artificial intelligence in clinical trials, moving beyond theoretical benefits to address practical challenges and measurable outcomes.

    Nov 4, 2025

  • Pangaea, Microsoft Collaboration, First-in-Class Monoclonal Antibody for Cancer, New LLM Tech

    Clinical Research News | Pangaea Data announces a collaboration with Microsoft; Ipsen acquires ImCheck Therapeutics; Flatiron Health released first-of-their-kind advances in LLM-extracted progression data and other uses; and more.

    Oct 29, 2025

  • Follow the Money: Best-in-Class Weight Loss Drug Trial, Novel eClinical Platform, Rheumatoid Arthritis, Other Diseases Treatments

    Clinical Research News | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Almac Group plans Almac Trial Coordinator, a first-in-class interoperable clinical trial technology platform; Elvara advances their upcoming phase 2 clinical trial of its lead candidate ELV001; and more.

    Oct 28, 2025

  • GenAI Agents and Regulatory Compliance: Streamlining Unstructured Data Extraction Gets a Lift from GenAI Agentic Frameworks

    Clinical Research News | Imagine that you’re a life sciences researcher tasked with answering a regulatory request that involves extracting meaningful data from over 200 clinical trial reports from various sources. You’re looking for patient demographics, study outcomes, adverse events, and dosage information. For decades, the industry has relied on manual effort, but GenAI agents enable far better unstructured data extraction.

    Oct 24, 2025